![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 13, 11676-11685, March 28, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Departments of The transcriptional activity of estrogen
receptor-
MTA1 Interacts with MAT1, a Cyclin-dependent
Kinase-activating Kinase Complex Ring Finger Factor, and
Regulates Estrogen Receptor Transactivation Functions*
§,
§,
,
,
,
, and
Molecular and Cellular
Oncology and ¶ Pathology, The University of Texas M. D. Anderson
Cancer Center, Houston, Texas 77030
is controlled by coregulators. MTA1
(metastasis-associated protein
1) represses estrogen receptor-
-driven transcription by
recruiting histone deacetylases (HDACs) to the estrogen response
element containing target gene chromatin in breast cancer cells. Using a yeast two-hybrid screen with the MTA1 C-terminal domain as bait, we
identified MAT1 (ménage á trois 1) as an MTA1-binding protein. MAT1 is an
assembly/targeting factor for cyclin-dependent
kinase-activating kinase (CAK), which has been shown to functionally
interact with general transcriptional factor TFIIH, a known inducer of
ER transactivation. We show that estrogen signaling promotes nuclear
translocation of MAT1 and that MTA1 interacts with MAT1 both in
vitro and in vivo. MAT1 binds to the C-terminal
389-441 amino acids GATA domain and N-terminal 1-164 amino acids
bromo-domain of MTA1, whereas MTA1 binds to the N-terminal ring finger
domain of the MAT1. In addition, MAT1 interacts with the activation
function 2 domain of ER and colocalizes with ER in activated cells.
MTA1 deregulation in breast cancer cells led to its interactions with
the CAK complex components, ER, and HDAC2. Accordingly, MTA1 inhibited
CAK stimulation of ER transactivation that was partially relieved by
HDAC inhibitor trichostatin A, suggesting that MTA1 might
inhibit CAK-induced transactivation function of ER by recruiting HDAC.
Furthermore, MTA1 overexpression inhibited the ability of CAK complex
to phosphorylate ER. Together, these findings identified MAT1 as a
target of MTA1 and provided new evidence to suggest that the
transactivation functions of ER might be influenced by the regulatory
interactions between CAK and MTA1 in breast cancer cells.
*
This work was supported in part by National Institutes of
Health Grant CA84456 and by Susan G. Komen Foundation Grant BCRT 2000835.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Molecular
and Cellular Oncology-108, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030.
This article has been cited by other articles:
![]() |
R. Bagheri-Yarmand, S. Balasenthil, A. E. Gururaj, A. H. Talukder, Y.-H. Wang, J. H. Lee, Y. S. Kim, X. Zhang, D. M. Jones, L. J. Medeiros, et al. Metastasis-Associated Protein 1 Transgenic Mice: A New Model of Spontaneous B-Cell Lymphomas Cancer Res., August 1, 2007; 67(15): 7062 - 7067. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Manavathi and R. Kumar Metastasis Tumor Antigens, an Emerging Family of Multifaceted Master Coregulators J. Biol. Chem., January 19, 2007; 282(3): 1529 - 1533. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Moisan, C. Larochelle, B. Guillemette, and L. Gaudreau BRCA1 Can Modulate RNA Polymerase II Carboxy-Terminal Domain Phosphorylation Levels Mol. Cell. Biol., August 15, 2004; 24(16): 6947 - 6956. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Talukder, A. Gururaj, S. K. Mishra, R. K. Vadlamudi, and R. Kumar Metastasis-Associated Protein 1 Interacts with NRIF3, an Estrogen-Inducible Nuclear Receptor Coregulator Mol. Cell. Biol., August 1, 2004; 24(15): 6581 - 6591. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bagheri-Yarmand, A. H. Talukder, R.-A. Wang, R. K. Vadlamudi, and R. Kumar Metastasis-associated protein 1 deregulation causes inappropriate mammary gland development and tumorigenesis Development, July 15, 2004; 131(14): 3469 - 3479. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |